about
Imaging in the management of ischemic cardiomyopathy: special focus on magnetic resonanceLong-term continuation on cardiovascular drug treatment in patients with coronary heart diseaseInter-study reproducibility of cardiovascular magnetic resonance myocardial feature tracking.Perfusion cardiovascular magnetic resonance: Comparison of an advanced, high-resolution and a standard sequence.Quantitative assessment of left ventricular mechanical dyssynchrony using cine cardiovascular magnetic resonance imaging: Inter-study reproducibility.Quantitative assessment of magnetic resonance derived myocardial perfusion measurements using advanced techniques: microsphere validation in an explanted pig heart system.Feasibility of high-resolution quantitative perfusion analysis in patients with heart failure.Myocardial feature tracking reduces observer-dependence in low-dose dobutamine stress cardiovascular magnetic resonanceQuantification of atrial dynamics using cardiovascular magnetic resonance: inter-study reproducibility.Impact of an abdominal belt on breathing patterns and scan efficiency in whole-heart coronary magnetic resonance angiography: comparison between the UK and Japan.Design and rationale of the MR-INFORM study: stress perfusion cardiovascular magnetic resonance imaging to guide the management of patients with stable coronary artery disease.Reproducibility of a cardiac magnetic resonance derived myocardial perfusion reserve index.Perfusion cardiovascular magnetic resonance and fractional flow reserve in patients with angiographic multi-vessel coronary artery disease.Comparing approaches to correct for respiratory motion in NH3 PET-CT cardiac perfusion imaging.Cardiovascular magnetic resonance imaging of isolated perfused pig hearts in a 3T clinical MR scanner.A direct comparison of the sensitivity of CT and MR cardiac perfusion using a myocardial perfusion phantom.Specialist intervention is associated with improved patient outcomes in patients with decompensated heart failure: evaluation of the impact of a multidisciplinary inpatient heart failure team.Cardiac magnetic resonance imaging to guide complex revascularization in stable coronary artery disease.The assessment of ischaemic burden: validation of a functional jeopardy score against cardiovascular magnetic resonance perfusion imaging.Electrical injury during "hands on" defibrillation-A potential risk of internal cardioverter defibrillators?Perfusion phantom: An efficient and reproducible method to simulate myocardial first-pass perfusion measurements with cardiovascular magnetic resonance.An isolated perfused pig heart model for the development, validation and translation of novel cardiovascular magnetic resonance techniques.Point-of-care platelet function assays demonstrate reduced responsiveness to clopidogrel, but not aspirin, in patients with Drug-Eluting Stent Thrombosis whilst on dual antiplatelet therapy.Combining carotid intima-media thickness with carotid plaque on screening for coronary heart disease.Cardiovascular magnetic resonance myocardial feature tracking for quantitative viability assessment in ischemic cardiomyopathy.The intra-observer reproducibility of cardiovascular magnetic resonance myocardial feature tracking strain assessment is independent of field strength.Registration of 3D trans-esophageal echocardiography to X-ray fluoroscopy using image-based probe tracking.Prognostic utility of BCIS myocardial jeopardy score for classification of coronary disease burden and completeness of revascularization.Impact of an abdominal belt on breathing patterns to improve the quality of whole-heart coronary magnetic resonance angiography: comparison between UK and Japan.Validation of dynamic three-dimensional whole heart magnetic resonance myocardial perfusion imaging at 3.0 Tesla against fractional flow reserve for the detection of flow-limiting coronary heart disease.Endsystolic versus enddiastolic scar imaging for transmurality assessment.Whole heart coronary MRA at 3.0T: a comparison between multi and single- RF transmission.Validation of dynamic three-dimensional whole heart magnetic resonance myocardial perfusion imaging at 3.0 Tesla against the duke jeopardy score to assess myocardium at risk.Comparison of MOLLI, shMOLLLI, and SASHA in discrimination between health and disease and relationship with histologically derived collagen volume fraction.Quantitative cardiovascular magnetic resonance perfusion imaging: inter-study reproducibility.Dual inversion-recovery mr imaging sequence for reduced blood signal on late gadolinium-enhanced images of myocardial scar.Multidisciplinary team approach to heart failure management.Correlation of Fractional Flow Reserve With Ischemic Burden Measured by Cardiovascular Magnetic Resonance Perfusion Imaging.Drug therapies in chronic heart failure: a focus on reduced ejection fraction.Ischemic burden by 3-dimensional myocardial perfusion cardiovascular magnetic resonance: comparison with myocardial perfusion scintigraphy.
P50
Q26824350-1AE49F7F-04D1-4A2B-9F90-82DA9E75E336Q28220890-900A6308-52F6-442A-A10A-F38216471070Q30462766-57DBF727-5891-4441-9368-424DFF93CD1BQ30522019-0931492B-469D-4923-929A-926665C855B6Q33707837-EE3E7A1A-062B-4652-AA1B-A948BA272B29Q34333363-71B170C5-83DF-43E8-B5E4-46B2AD82D5F4Q35078192-D0110F62-9294-4B80-ADE5-F8F0FD030E79Q35304674-8C32CC2B-6751-4876-BA75-E25B6E0875B1Q35616536-8E278BBE-3C91-4113-9575-59234448BEFCQ35661842-CFBC6399-BC97-494F-8BBB-1CE8AA861DF6Q36498991-6D1618D2-1247-48E6-8750-D0DE89500599Q36972976-C045BDDC-59F2-4A72-811D-15A5BE928B65Q37105989-3D8DFA37-E3A4-44CB-8F1E-28D0D3B722FFQ37273115-254917CD-C4D9-46F2-8DCD-B71329C0630FQ37319037-165DC1CB-650D-4CE2-B2EF-D3E86A909176Q37714888-2B4E4562-BE67-49CF-8803-D43C71794C35Q37741705-1EE279B2-023C-49E0-BDDF-78F8D7FDE769Q37779678-0B2058BE-D2C7-4A4A-B253-0ADC5113575AQ39264252-DE3005D2-B471-4865-9D67-35F5B84FFF5CQ39979350-C7EA8F29-DF01-49B4-B1F8-24444764C1A3Q41368879-1ADF2F8B-BC7F-4CA0-A174-5E071F9BA374Q42413948-7CD41C55-059C-468B-A0FB-D9D49469361AQ43077737-1DD28E38-A02C-4E78-9D85-A57F764F2702Q43266766-CCAF6C06-8758-4046-A3B8-157E7BED9D67Q43410572-BA838B69-0566-4818-B397-27F3349C3B7FQ43705006-CE3BF7CF-12C1-4197-90F8-97E24E0BC7B6Q45220295-2AD02D66-FFB0-4981-BEF1-68AFE8F604C3Q45376731-9B4DAD5B-E7D2-40D6-827C-5D09A00C0ADAQ45840433-4853F3C5-349A-40BD-9F93-7A11EF853A75Q45967187-7E825B44-87EF-49A6-8D7B-29710021468AQ46313349-622460BB-9408-44E6-85B3-B6E71092A437Q46601508-A0C23B19-877A-4CB2-9701-EA4C344252A6Q47155447-7B1DA21A-D3CA-401F-923B-F2A57AC407ACQ47297387-AD644A43-45EA-4A62-8BF2-A54DC5885C81Q47706767-802A8A78-8E8E-403E-8E4D-B8C65DCD9390Q47759097-0CCF6D21-C908-4022-8A89-0BA8CEAFB001Q48245420-1CEA86B8-A626-46B7-A540-67E7B80772D5Q48742562-769D045E-B1A3-485F-8D50-C3030E91FD1CQ52329580-1EC693A2-27AE-4FDC-B8ED-297AF90DF338Q52839582-37E46537-C095-420F-B3CC-D5DEE2911B01
P50
name
Geraint Morton
@ast
Geraint Morton
@en
Geraint Morton
@nl
type
label
Geraint Morton
@ast
Geraint Morton
@en
Geraint Morton
@nl
prefLabel
Geraint Morton
@ast
Geraint Morton
@en
Geraint Morton
@nl